IP Verse

Mirnas As Biomarkers For Distinguishing Benign From Malignant Thyroid Neoplasms - EP2772550

The patent EP2772550 was granted to Asuragen on Mar 29, 2017. The application was originally filed on Nov 17, 2011 under application number EP14150739A. The patent is currently recorded with a legal status of "Revoked".

EP2772550

ASURAGEN
Application Number
EP14150739A
Filing Date
Nov 17, 2011
Status
Revoked
Nov 4, 2022
Grant Date
Mar 29, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

URQUHART DYKES & LORDDec 27, 2017- -

Patent Citations (130) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONGB19880003000
DESCRIPTIONUS20030667126
DESCRIPTIONUS20050141707
DESCRIPTIONUS20050273640
DESCRIPTIONUS20060567082
DESCRIPTIONUS20060869295
DESCRIPTIONUS20070857948
DESCRIPTIONEP0266032
DESCRIPTIONEP0373203
DESCRIPTIONEP0785280
DESCRIPTIONEP0799897
DESCRIPTIONUS4659774
DESCRIPTIONUS4682195
DESCRIPTIONUS4683202
DESCRIPTIONUS4704362
DESCRIPTIONUS4816571
DESCRIPTIONUS4959463
DESCRIPTIONUS5141813
DESCRIPTIONUS5143854
DESCRIPTIONUS5202231
DESCRIPTIONUS5221619
DESCRIPTIONUS5223618
DESCRIPTIONUS5242974
DESCRIPTIONUS5264566
DESCRIPTIONUS5288644
DESCRIPTIONUS5324633
DESCRIPTIONUS5384261
DESCRIPTIONUS5405783
DESCRIPTIONUS5411876
DESCRIPTIONUS5412087
DESCRIPTIONUS5413924
DESCRIPTIONUS5424186
DESCRIPTIONUS5428148
DESCRIPTIONUS5429807
DESCRIPTIONUS5432049
DESCRIPTIONUS5436327
DESCRIPTIONUS5445934
DESCRIPTIONUS5468613
DESCRIPTIONUS5470710
DESCRIPTIONUS5470967
DESCRIPTIONUS5472672
DESCRIPTIONUS5480980
DESCRIPTIONUS5492806
DESCRIPTIONUS5503980
DESCRIPTIONUS5510270
DESCRIPTIONUS5525464
DESCRIPTIONUS5527681
DESCRIPTIONUS5529756
DESCRIPTIONUS5532128
DESCRIPTIONUS5545531
DESCRIPTIONUS5547839
DESCRIPTIONUS5550044
DESCRIPTIONUS5554501
DESCRIPTIONUS5554744
DESCRIPTIONUS5556752
DESCRIPTIONUS5561071
DESCRIPTIONUS5571639
DESCRIPTIONUS5574146
DESCRIPTIONUS5580726
DESCRIPTIONUS5580732
DESCRIPTIONUS5583013
DESCRIPTIONUS5593839
DESCRIPTIONUS5599672
DESCRIPTIONUS5599695
DESCRIPTIONUS5602244
DESCRIPTIONUS5610287
DESCRIPTIONUS5624711
DESCRIPTIONUS5631134
DESCRIPTIONUS5639603
DESCRIPTIONUS5645897
DESCRIPTIONUS5654413
DESCRIPTIONUS5658734
DESCRIPTIONUS5661028
DESCRIPTIONUS5665547
DESCRIPTIONUS5667972
DESCRIPTIONUS5695940
DESCRIPTIONUS5700637
DESCRIPTIONUS5705629
DESCRIPTIONUS5744305
DESCRIPTIONUS5800992
DESCRIPTIONUS5807522
DESCRIPTIONUS5830645
DESCRIPTIONUS5837196
DESCRIPTIONUS5847219
DESCRIPTIONUS5871928
DESCRIPTIONUS5876932
DESCRIPTIONUS5886165
DESCRIPTIONUS5919626
DESCRIPTIONUS5985619
DESCRIPTIONUS6004755
DESCRIPTIONUS6087102
DESCRIPTIONUS6368799
DESCRIPTIONUS6383749
DESCRIPTIONUS6403341
DESCRIPTIONUS6617112
DESCRIPTIONUS6638717
DESCRIPTIONUS6720138
DESCRIPTIONUS6723509
DESCRIPTIONWO0138580
DESCRIPTIONWO0168255
DESCRIPTIONWO03020898
DESCRIPTIONWO03022421
DESCRIPTIONWO03023058
DESCRIPTIONWO03029485
DESCRIPTIONWO03040410
DESCRIPTIONWO03053586
DESCRIPTIONWO03066906
DESCRIPTIONWO03067217
DESCRIPTIONWO03076928
DESCRIPTIONWO03087297
DESCRIPTIONWO03091426
DESCRIPTIONWO03093810
DESCRIPTIONWO03100012
DESCRIPTIONWO03100448
DESCRIPTIONWO2004020085
DESCRIPTIONWO2004027093
DESCRIPTIONWO9317126
DESCRIPTIONWO9511995
DESCRIPTIONWO9521265
DESCRIPTIONWO9521944
DESCRIPTIONWO9535505
DESCRIPTIONWO9631622
DESCRIPTIONWO9710365
DESCRIPTIONWO9727317
DESCRIPTIONWO9743450
DESCRIPTIONWO9923256
DESCRIPTIONWO9935505
DESCRIPTIONWO9936760
OPPOSITIONWO2010073248
SEARCHCN101423869

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ANDERSEN ET AL., CANCER RES., (2004), vol. 64, no. 15, pages 5245 - 5250
DESCRIPTION- CARRINGTON; AMBROS, SCIENCE, (2003), vol. 301, no. 5631, pages 336 - 338
DESCRIPTION- CHEN ET AL., MOL. ENDOCRINOL., (2005), vol. 19, pages 441 - 458
DESCRIPTION- CUMMINS ET AL., IRT: NUCLEOSIDES AND NUCLEOSIDES, (1996), page 72
DESCRIPTION- DENLI ET AL., TRENDS BIOCHEM. SCI., (2003), vol. 28, page 196
DESCRIPTION- DIDENKO, BIOTECHNIQUES, (2001), vol. 31, no. 5, pages 1106 - 16,1118,1120-1
DESCRIPTION- EMPTAGE ET AL., NEURON, (2001), vol. 29, no. 1, pages 197 - 208
DESCRIPTION- FROEHLER ET AL., NUCLEIC ACIDS RES., (1986), vol. 14, no. 13, pages 5399 - 5407
DESCRIPTION- GRIFFEY ET AL., J. MASS SPECTROM, (1997), vol. 32, no. 3, pages 305 - 13
DESCRIPTION- GRIFFITHS-JONES ET AL., NUCLEIC ACIDS RES., (2006), vol. 34, pages D140 - D144
DESCRIPTION- HUBER ET AL., BIOINFORMATICS, (2002), vol. 18, no. S1, pages S96 - S104
DESCRIPTION- ITAKURA; RIGGS, SCIENCE, (1980), vol. 209, pages 1401 - 1405
DESCRIPTION- KLOSTERMEIER; MILLAR, BIOPOLYMERS, (2001), vol. 61, no. 3, pages 159 - 79
DESCRIPTION- LEE ET AL., BIOCHIM. BIOPHYS. ACTA, (2002), vol. 1582, pages 175 - 177
DESCRIPTION- OLSEN ET AL., DEV. BIOL., (1999), vol. 216, page 671
DESCRIPTION- SEGGERSON ET AL., DEV. BIOL., (2002), vol. 243, page 215
OPPOSITION- AHERNE et al., Downloaded, URL: https://molecular- supplemental data cancer.biomedcentral.com/articles/10.1186/1476-4598-7- 89#Sec20, XP055450007
OPPOSITION- "Mature sequence hsa-miR-146b-5p", miRBase, (20170000), Database accession no. MIMAT0002809, XP055450009
OPPOSITION- HE et al., "The Role of microRNA Genes in Papillary Thyroid Carcinoma", Proc. Natl. Acad. Sci USA, (20050000), vol. 102, no. 52, pages 19075 - 19080, XP002615378
OPPOSITION- AHERNE et al., "Geographical Mapping of a Multifocal Thyroid Tumour Using (2008) Genetic Alteration Analysis & miRNA Profiling", Molecular Cancer, (20080000), vol. 7, page 89, XP021043756
OPPOSITION- NIKIFOROVA et al., "MicroRNA Expression Profiling of Thyroid Tumors: Biological (2008) Significance and Diagnostic Utility", J. Clin Endocrin Metab., (20080000), vol. 93, no. 5, pages 1600 - 1608, XP002636292
OPPOSITION- CHUDOVA et al., "Molecular Classification of Thyroid Nodules Using High- (2010) Dimensionality Genomic Data", J. Clin. Endocrinol. Metab., (20100000), vol. 95, no. 12, pages 5296 - 5304, XP002720667
SEARCH- ESZLINGER MARKUS ET AL, "Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.", MOLECULAR AND CELLULAR ENDOCRINOLOGY 30 JUN 2010 LNKD- PUBMED:20083161, (20100630), vol. 322, no. 1-2, ISSN 1872-8057, pages 29 - 37, XP002679857 [A] 1-13 * abstract * * page 34, paragraph 5 - page 35 *
SEARCH- CHEN YAO-TSENG ET AL, "MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.", MODERN PATHOLOGY : AN OFFICIAL JOURNAL OF THE UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY, INC SEP 2008 LNKD- PUBMED:18587330, (200809), vol. 21, no. 9, ISSN 1530-0285, pages 1139 - 1146, XP002679856 [A] 1-13 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents